Surgery for Bentall endocarditis: short- and midterm outcomes from a multicentre registry

  • Sandro Sponga
    Cardiothoracic Department, University Hospital of Udine, DAME Udine Medical School, Udine, Italy
  • Michele Di Mauro
    Cardiac Surgery, University “G. D’Annunzio” Chieti-Pescara, Chieti, Italy
  • Pietro G Malvindi
    Division of Cardiac Surgery, Santa Maria Hospital, GVM Care & Research, Bari, Italy
  • Domenico Paparella
    Division of Cardiac Surgery, Santa Maria Hospital, GVM Care & Research, Bari, Italy
  • Giacomo Murana
    Cardiac Surgery, S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
  • Davide Pacini
    Cardiac Surgery, S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
  • Luca Weltert
    Cardiac Surgery, European Hospital, Roma, Italy
  • Ruggero De Paulis
    Cardiac Surgery, European Hospital, Roma, Italy
  • Giangiuseppe Cappabianca
    Cardiac Surgery, University Hospital, Varese, Italy
  • Cesare Beghi
    Cardiac Surgery, University Hospital, Varese, Italy
  • Carlo De Vincentiis
    Cardiac Surgery, San Donato IRCCS Hospital, San Donato Milanese, Milan, Italy
  • Alessandro Parolari
    Cardiac Surgery, San Donato IRCCS Hospital, San Donato Milanese, Milan, Italy
  • Antonio Messina
    Cardiac Surgery, Poliambulanza Foundation Hospital, Brescia, Italy
  • Giovanni Troise
    Cardiac Surgery, Poliambulanza Foundation Hospital, Brescia, Italy
  • Antonio Salsano
    Cardiac Surgery, IRCCS San Martino-IST, University Hospital, Genova, Italy
  • Francesco Santini
    Cardiac Surgery, IRCCS San Martino-IST, University Hospital, Genova, Italy
  • Michele D Pierri
    Cardiac Surgery, Ospedali Riuniti “Umberto I-Lancisi-Salesi”, Ancona, Italy
  • Marco Di Eusanio
    Cardiac Surgery, Ospedali Riuniti “Umberto I-Lancisi-Salesi”, Ancona, Italy
  • Daniele Maselli
    Cardiac Surgery, S. Anna Hospital, Catanzaro, Italy
  • Guglielmo Actis Dato
    Cardiac Surgery, Mauriziano Hospital, Turin, Italy
  • Paolo Centofanti
    Cardiac Surgery, Mauriziano Hospital, Turin, Italy
  • Samuel Mancuso
    Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy
  • Mauro Rinaldi
    Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy
  • Giuseppe Cagnoni
    Cardiac Surgery, Sacco Hospital, University of Milan, Milan, Italy
  • Carlo Antona
    Cardiac Surgery, Sacco Hospital, University of Milan, Milan, Italy
  • Marco Picichè
    Cardiac Surgery, S Bartolo Hospital, Vicenza, Italy
  • Loris Salvador
    Cardiac Surgery, S Bartolo Hospital, Vicenza, Italy
  • Diego Cugola
    Cardiac Surgery, Papa Giovanni XXIII Hospital, Bergamo, Italy
  • Lorenzo Galletti
    Cardiac Surgery, Papa Giovanni XXIII Hospital, Bergamo, Italy
  • Alberto Pozzoli
    Cardiac Surgery, Vita e Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy
  • Michele De Bonis
    Cardiac Surgery, Vita e Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy
  • Roberto Lorusso
    Cardio-Thoracic Surgery Department, Heart & Vascular Centre, Cardiovascular Research Institute, Maastricht, Netherlands
  • Uberto Bortolotti
    Cardiac Surgery, Santa Chiara University Hospital, Pisa, Italy
  • Ugolino Livi
    Cardiothoracic Department, University Hospital of Udine, DAME Udine Medical School, Udine, Italy

抄録

<jats:title>Abstract</jats:title> <jats:p /> <jats:sec> <jats:title>OBJECTIVES</jats:title> <jats:p>Endocarditis after the Bentall procedure is a severe disease often complicated by a pseudoaneurysm or mediastinitis. Reoperation is challenging but conservative therapy is not effective. The aim of this study was to assess short- and midterm outcomes of patients reoperated on for Bentall-related endocarditis.</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS</jats:title> <jats:p>Seventy-three patients with Bentall procedure-related endocarditis were recorded in the Italian registry. The mean age was 57 ± 14 years and 92% were men; preoperative comorbidities included hypertension (45%), diabetes (12%) and renal failure (11%). The logistic EuroSCORE was 25%; the EuroSCORE II was 8%.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>Preoperatively, 12% of the patients were in septic shock; left ventricular-aortic discontinuity was present in 63% and mitral valve involvement occurred in 12%. The most common pathogens were Staphylococcus aureus (22%) and Streptococci (14%). Reoperations after a median interval of 30 months (1–221 months) included a repeat Bentall with a bioconduit (41%), a composite mechanical (33%) or biological valved conduit (19%) and a homograft (6%). In 1 patient, a heart transplant was required (1%); in 12%, a mitral valve procedure was needed. The hospital mortality rate was 15%. The postoperative course was complicated by renal failure (19%), major bleeding (14%), pulmonary failure (14%), sepsis (11%) and multiorgan failure (8%). At multivariate analysis, urgent surgery was a risk factor for early death [hazard ratio 20.5 (1.9–219)]. Survival at 5 and 8 years was 75 ± 6% and 71 ± 7%, with 3 cases of endocarditis relapse.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS</jats:title> <jats:p>Surgery is effective in treating endocarditis following the Bentall procedure although it is associated with high perioperative mortality and morbidity rates. Endocarditis relapse seems to be uncommon.</jats:p> </jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ